Showing 71 - 80 of 154
This paper presents a model economy with endogenous credit constraints and endogenous growth, in which agents face a trade-off between investing resources to improve the pledgeability of collateral assets and the accumulation of human capital. The model generates both growth miracles and...
Persistent link: https://www.econbiz.de/10012926160
The increasing waves of globalization, the first taking place between the second half of the last century and WWI, and the second which has occurred since WWII until today, implied an unprecedented flow of goods and factors across international borders. The first episode of mass migration dates...
Persistent link: https://www.econbiz.de/10012773855
In this paper, we empirically assess the evolution of the aggregate hours worked, with a particular emphasis on their age structure, in a sample of OECD countries, along the period 1970-2007. We show that the age composition of the workforce has a large and statistically signicant effect on...
Persistent link: https://www.econbiz.de/10012951536
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). Through a...
Persistent link: https://www.econbiz.de/10012768128
Persistent link: https://www.econbiz.de/10013185751
Persistent link: https://www.econbiz.de/10013189353
Persistent link: https://www.econbiz.de/10012806489
We examine a theoretical model of liquidity with three assets - money, government bonds and equity - that are used for transaction purposes. Money and bonds complement each other in the payment system. The liquidity of equity is derived as an equilibrium outcome. Liquidity cycles arise from the...
Persistent link: https://www.econbiz.de/10013323786
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). Through a...
Persistent link: https://www.econbiz.de/10012464081
Persistent link: https://www.econbiz.de/10011924285